1 2 3 4 5 6 7 8 UNITED STATES DISTRICT COURT 9 SOUTHERN DISTRICT OF CALIFORNIA 10 11 RYAN L., Case No.: 23-cv-338-DDL
12 Plaintiff, ORDER AFFIRMING 13 v. COMMISSIONER’S DECISION
14 MARTIN O’MALLEY, Commissioner of 15 Social Security,1 Defendant. 16 17 18 Plaintiff Ryan L. seeks judicial review of the Social Security Commissioner’s 19 denial of his application for disability benefits. See Dkt. No. 1. The parties have 20 consented to the undersigned’s jurisdiction. Dkt. No. 6. Plaintiff moves the Court 21 to remand his application to the Social Security Administration for an award of 22 benefits or, alternatively, for further proceedings. See generally Dkt. No. 15. For 23 the reasons stated below, the Court finds the Commissioner’s determination that 24 Plaintiff is not disabled is free of legal error and supported by substantial evidence. 25 The Commissioner’s decision is therefore AFFIRMED. 26 27 1 Commissioner O’Malley is automatically substituted pursuant to Federal 28 1 I. 2 BACKGROUND 3 A. Plaintiff’s Application for Disability Benefits 4 On January 30, 2020, Plaintiff filed an application for disability insurance 5 benefits and supplemental security income under Titles II and XVI of the Social 6 Security Act (the “Act”), alleging his fibromyalgia, chronic pain, asthma, depression 7 and other conditions rendered him unable to work as of June 19, 2015. See 8 Certified Administrative Record (“AR”) [Dkt. Nos. 9, 10] at 592, 628, 642, 684.2 9 After his application was denied at the initial stage and upon reconsideration, 10 Plaintiff requested a hearing before an administrative law judge (“ALJ”), which took 11 place on June 29, 2021 before ALJ Eric Benham. Id. at 592, 608-627. Plaintiff 12 appeared with counsel and gave testimony. Id. The ALJ issued an unfavorable 13 decision on December 21, 2021,3 having concluded Plaintiff “has not been under 14 a disability, as defined in [the Act], from June 19, 2015, through the date of [the] 15 decision.” Id. at 601-02. On January 19, 2023, the Appeals Council denied review, 16 and the ALJ’s decision became final. See id. at 799-801. 17 B. Summary of the ALJ’s Findings 18 A person is considered “disabled” within the meaning of the Act if they suffer from 19 a medically determinable physical or mental impairment which is expected to last 20 at least a year and is of such severity that they cannot work, considering their 21 / / / 22 / / / 23 / / / 24
25 2 The Court uses the parties’ pagination of the AR. All other docket citations 26 are to the CM/ECF page numbers. 27 3 Plaintiff erroneously identified the date of the ALJ’s decision as December 28 16, 2021. Dkt. No. 15 at 2. 1 age, education, and work experience. See 42 U.S.C. § 423(d). The Administration 2 employs a sequential five-step evaluation to make this determination.4 3 The ALJ followed this five-step process in adjudicating Plaintiff’s disability 4 claim. See generally AR at 589-607. At step one, the ALJ found Plaintiff had not 5 engaged in substantial gainful activity since June 19, 2015, the alleged date of 6 onset of his disability. Id. at 594. At step two, the ALJ found Plaintiff had the 7 following severe impairments: fibromyalgia syndrome; lumbar spine degenerative 8 joint disease and degenerative disc disease; chronic pain syndrome; and asthma.5 9 AR at 595. At step three, the ALJ found Plaintiff’s impairments did not meet or 10 medically equal a listed impairment. Id. at 597. 11 Proceeding to step four, the ALJ determined despite Plaintiff’s impairments, 12 he could: 13
14 4 The five-step sequential evaluation is the same for both disability insurance 15 benefits and supplemental security income. See 20 C.F.R. § 404.1520; 20 C.F.R. 16 § 416.920. The ALJ must determine the following: at step one, whether the claimant is engaged in substantial gainful activity; at step two, whether the claimant 17 suffers from a severe impairment within the meaning of the regulations; at step 18 three (if the claimant suffers from a severe impairment), whether the impairment meets or is medically equal to one of the impairments identified in the Listing of 19 Impairments; at step four, the claimant’s residual functional capacity (“RFC”) based 20 on all impairments and whether, given the RFC, the claimant can perform his or her past relevant work; at step five, whether the claimant can make an adjustment 21 to other work based on his or her RFC. If the claimant is found not disabled at any 22 step, the analysis does not proceed to the next step.
23 5 Plaintiff also suffers from gastroesophageal reflux disease (“GERD”), eosinophilic esophagitis, and obstructive sleep apnea, but the ALJ found “little 24 evidence” that these conditions limited Plaintiff’s ability to perform work activities 25 and therefore deemed these conditions not severe. AR at 595. The ALJ likewise found Plaintiff’s medically determinable mental impairments of attention deficit 26 hyperactivity disorder, possible autism spectrum disorder, and depressive disorder 27 were non-severe, finding the record did not demonstrate they caused “more than mild” limitations in the Paragraph B criteria. Id. at 595-96. Plaintiff does not 28 1 perform a range of light work as defined in 20 CFR [§] 404.1567(b) and 416.967(b) as follows: lift as much as 20 pounds frequently; stand and 2 walk 6 hours in an 8-hour day; sit 6 hours in an 8-hour day; would be 3 limited to occasional stooping, crouching, kneeling, crawling, as well as climbing stairs, or ladders or scaffolds; [and should] avoid work in 4 [any] environment that would expose him to concentrated extreme 5 cold, vibrations, or pulmonary irritants. 6 AR at 598. 7 In formulating this RFC, the ALJ considered Plaintiff’s subjective testimony 8 regarding his limitations. Id. at 598-99. The ALJ found Plaintiff’s medically 9 determinable impairments could reasonably be expected to cause Plaintiff’s 10 alleged symptoms, but that the objective medical evidence did not support 11 Plaintiff’s allegations as to their limiting effects. Id. As discussed in more detail 12 below, the ALJ noted Plaintiff’s impairments were effectively treated with 13 medications and other conservative measures, including behavioral therapy and 14 physical rehabilitation. Id. at 599. The ALJ also noted Plaintiff’s treatment history 15 was “infrequent,” and there was no evidence of progressively escalating 16 treatments or “additional interventions” despite allegations of worsening pain and 17 other limitations. Id. For the same reasons, the ALJ found Plaintiff’s “statements 18 about the level of pain associated with his impairments leading to . . . limited daily 19 activities are not fully consistent with the objective medical evidence of record.” Id. 20 The ALJ also considered the opinion evidence and prior administrative 21 medical findings in the record. AR at 600. Based upon their review of the medical 22 record, state agency medical consultants M. Mazuryk, M.D. and T. Do, M.D. both 23 assessed Plaintiff as able to perform light work, subject to additional environmental 24 limitations. Id. Consultative internist A. Kanner, M.D., opined Plaintiff was capable 25 of medium work. Based on his review of the record and the consistency of the 26 consultants’ opinions with that record, the ALJ found the Drs. Mazuryk’s and Do’s 27 assessments persuasive but found Dr. Kanner’s opinion “less persuasive.” Id. 28 / / / 1 Having considered the record as described above, ALJ concluded: 2 The above residual functional capacity assessment is supported by the 3 totality of the evidence including the prior administrative medical findings from the state agency medical consultants and the consistent 4 notation of normal physical examinations in the file. [Plaintiff] does 5 have underlying impairments that do cause some symptoms of pain. However, the treatment provided that is only in the form of medications 6 and the notation that being off medications for a few months only 7 resulted in a 10% increase in the symptoms of pain without the need for further intervention shows [Plaintiff’s] pain symptoms are not as 8 significant as alleged. 9 10 Id. at 600-01. Based on the above RFC and the testimony of the vocational expert, 11 the ALJ further found at step four Plaintiff could perform his past relevant work as 12 User Support Analyst as that position is generally performed in the national 13 economy. Id. at 601. Accordingly, the ALJ did not proceed to step five but instead 14 concluded Plaintiff was not disabled within the meaning of the Act. Id. at 601-02; 15 see 20 C.F.R. § 404.1520(a)(4)(iv) (“If you can still do your past relevant work, we 16 will find that you are not disabled.”); 20 C.F.R. § 416.920(a)(4)(iv) (same). 17 II. 18 DISPUTED ISSUES 19 The issue before the Court is whether the ALJ provided specific, clear and 20 convincing reasons to reject Plaintiff’s subjective assessment of the limiting effects 21 of his impairments. See Dkt. No. 15 at 4, 10. 22 III. 23 STANDARD OF REVIEW 24 The Court’s review of the Commissioner’s final decision is “highly 25 deferential.” Kitchen v. Kijakazi, 82 F. 4th 732, 738 (9th Cir. 2023).6 The Court 26 27 6 All citations, internal quotation marks, and subsequent history are omitted 28 1 “will disturb the denial of benefits only if the decision contains legal error or is not 2 supported by substantial evidence.” Id. “Substantial evidence is such relevant 3 evidence that a reasonable mind might accept as adequate to support a 4 conclusion, and must be more than a mere scintilla, but may be less than a 5 preponderance.” Id. This Court must review the entire record and consider 6 adverse as well as supporting evidence. See Ahearn v. Saul, 988 F.3d 1111, 1115 7 (9th Cir. 2021). The Court “may not reweigh the evidence or substitute [its] 8 judgment for that of the ALJ.” Id. Moreover, “[t]he ALJ is responsible for 9 determining credibility, resolving conflicts in medical testimony, and for resolving 10 ambiguities.” Id. If the evidence is susceptible of more than one rational 11 interpretation, the ALJ’s decision must be upheld. See id. at 1115-16. However, 12 the Court cannot affirm “on a ground upon which [the ALJ] did not rely.” Garrison 13 v. Colvin, 759 F.3d 995, 1010 (9th Cir. 2014). Where the ALJ commits legal error, 14 the Court may affirm the decision if the error is harmless, meaning “it is 15 inconsequential to the ultimate nondisability determination, or that, despite the 16 legal error, the agency’s path may reasonably be discerned, even if the agency 17 explains its decision with less than ideal clarity.” Brown-Hunter v. Colvin, 806 F.3d 18 487, 492 (9th Cir. 2015). 19 IV. 20 DISCUSSION 21 A. The ALJ Did Not Err in Evaluating Plaintiff’s Subjective Testimony 22 1. Legal Standards 23 “[T]he credibility determination is exclusively the ALJ’s to make, and [the 24 Court’s] only to review.” Brown-Hunter, 806 F.3d at 494. In assessing whether to 25 credit a claimant’s subjective testimony regarding their functional limitations, the 26 ALJ follows a two-step process. “First, the ALJ must determine whether the 27 claimant has presented objective medical evidence of an underlying impairment 28 which could reasonably be expected to produce the pain or other symptoms 1 alleged.” Ferguson v. O’Malley, --- F.4th ---, 2024 WL 1103364, at *3 (9th Cir. Mar. 2 14, 2024). When a claimant satisfies the first step, and absent any evidence of 3 malingering, “the ALJ can reject the claimant’s testimony . . . only by offering 4 specific, clear and convincing reasons for doing so.” Id.; see also Smartt v. 5 Kijakazi, 53 F.4th 489, 497 (9th Cir. 2022) (“an adverse credibility finding must be 6 based on clear and convincing reasons”). 7 The Ninth Circuit has explained that “the ʻclear and convincing’ standard . . . 8 requires an ALJ to show his work.” Smartt, 53 F.4th at 499. Requiring an ALJ to 9 support their credibility determination with specific findings enables the reviewing 10 court to determine whether the ALJ “arbitrarily discredit[ed] [the] claimant’s 11 testimony.” Thomas v. Barnhart, 278 F.3d 947, 958 (9th Cir. 2002); accord 12 Lambert v. Saul, 980 F.3d 1266, 1277 (9th Cir. 2020) (noting that “the ALJ must 13 provide sufficient reasoning” to “permit meaningful review”). If the ALJ does not 14 provide sufficient reasons for rejecting the claimant’s testimony, “then the ALJ’s 15 credibility determination is not supported by substantial evidence.” Ferguson, 16 2024 WL 1103364, at *3. However, if the ALJ’s credibility determination is 17 adequately supported, this Court “may not engage in second-guessing.” Thomas, 18 278 F.3d at 959. 19 The Administration has issued guidance for the evaluation of fibromyalgia- 20 based disability claims. See Social Security Administration, Social Security Ruling 21 12-2p: Titles II and XVI: Evaluation of Fibromyalgia (2012) (hereafter “SSR 12- 22 2p”).7 Fibromyalgia, the Administration explains, “is a complex medical condition 23 characterized primarily by widespread pain in the joints, muscles, tendons, or 24 25 26 7 SSRs are the Administration’s “precedent final opinions and orders and 27 statements of policy and interpretations,” and are binding on the ALJ although they “do not carry the force of law.” See Bray v. Comm'r of Soc. Sec. Admin., 554 F.3d 28 1 nearby soft tissues that has persisted for at least 3 months.” See id. There is no 2 objective test for fibromyalgia; for purposes of a disability claim, the impairment is 3 established through the patient’s subjective reports of pain and corroborated by 4 either a physical examination of so-called “tender points” or the “repeated 5 manifestation” of certain coextensive conditions, together with evidence that other 6 potential causes of the patient’s symptoms have been ruled out. See generally 7 SSR 12-2p. “In evaluating whether a claimant’s residual functional capacity 8 renders them disabled because of fibromyalgia, the medical evidence must be 9 construed in light of fibromyalgia’s unique symptoms and diagnostic methods . . ..” 10 Revels v. Berryhill, 874 F.3d 648, 662 (9th Cir. 2017). Because a person with 11 fibromyalgia “may have ‘bad days and good days,’” the ALJ must “look[] at the 12 longitudinal records” to the extent possible. Id. at 663. 13 A fibromyalgia diagnosis does not per se require a finding of disability, 14 however. See SSR 12-2p (noting fibromyalgia “is not a listed impairment”). The 15 ALJ is not bound by a claimant’s subjective testimony, and can and should 16 consider other medical and non-medical evidence to determine whether a claimant 17 is rendered disabled by fibromyalgia. See Diane B. v. Kijakazi, No. 21-cv-00794- 18 TSH, 2022 WL 94915, at *9 (N.D. Cal. Jan. 10, 2022) (“The Court is aware of no 19 authority that requires an ALJ to give dispositive weight to [p]laintiff’s symptom 20 allegations simply because they were associated with fibromyalgia.”). Indeed, 21 SSR 12-2p directs the ALJ to consider the “longitudinal records” to “establish[] both 22 the existence and severity of the impairment.” See SSR 12-2p (emphasis added). 23 Furthermore, although Plaintiff focuses most of his argument on the unique 24 nature of fibromyalgia, Plaintiff also alleged disability based on other impairments, 25 some of which (namely, lumbar spine degenerative joint disease and degenerative 26 disc disease, chronic pain, and asthma) the ALJ found to be severe. AR at 595. 27 Whether Plaintiff’s alleged disability is due to fibromyalgia or another impairment, 28 the ALJ was required to employ the two-step process described above to evaluate 1 Plaintiff’s subjective reports of the limiting effects of his impairments. See SSR 12- 2 2p; SSR 16-3p. 3 2. Application 4 Plaintiff asserts the ALJ’s discrediting of Plaintiff’s subjective symptom 5 testimony reflects “a fundamental misunderstanding of fibromyalgia,” and that the 6 ALJ failed to appreciate the relationship between Plaintiff’s fibromyalgia and his 7 other conditions. Id. at 7-8. Plaintiff further asserts the ALJ’s “rationale” for 8 rejecting Plaintiff’s symptom testimony is “insufficient” and that the ALJ “failed to 9 articulate legally sufficient reasons for rejecting the testimony and fibromyalgia 10 issues of [Plaintiff].” Dkt. No. 15 at 10. The Court disagrees. 11 After reviewing the evidence in the record, the ALJ determined Plaintiff’s 12 fibromyalgia, chronic pain, degenerative conditions in his lower back, and asthma 13 could reasonably be expected to cause his alleged symptoms. AR at 598. 14 However, the ALJ found the evidence in the record did not support Plaintiff’s 15 allegations regarding the extent to which those symptoms limited his ability to 16 work.8 Id. at 599. Insofar as the ALJ found Plaintiff’s testimony credible, 17 appropriate limitations were reflected in the RFC. Id. at 600. 18 The Court turns first to the ALJ’s assessment of Plaintiff’s allegations of 19 disabling pain and fatigue. Plaintiff testified he was prevented from working 20 because his “fatigue is quite severe,” his fibromyalgia “makes standing [and] sitting 21 quite painful” for anything “longer than 5 minutes,” and his “fingers cramp up within 22 minutes of doing any tasks . . . even holding a glass” or typing. Id. at 613, 616. 23 Plaintiff stated if absolutely necessary, he might be able to lift 20 pounds but would 24 25 8 Plaintiff chides the ALJ for “clump[ing]” his symptoms together, Dkt. No. 15 26 at 7, but Plaintiff himself stated “all [his] medical conditions . . . compound[ed]” to 27 prevent him from working. AR at 612. The Court finds it was appropriate for the ALJ to address Plaintiff’s allegations of disabling pain and fatigue by reference to 28 1 experience pain for “three or four hours” afterward, and to avoid pain and possible 2 injury he should not lift “anything more than . . . two or three pounds.” Id. at 617. 3 Plaintiff further testified even performing small tasks like brushing his teeth or 4 “scrubbing up in the shower” causes his muscles to “instantly feel like they’re on 5 fire.” Id. at 617-18. Due to his pain and fatigue, “from the moment [he] wake[s] 6 up,” he will “get some food and . . . sit in the recliner pretty much all day until I go 7 to bed.” Id. at 618. He rarely leaves the house “because it’s just too much, you 8 know, just too painful and not really worth it.” Id. at 621. 9 In finding these allegations less than credible, the ALJ identified that 10 Plaintiff’s fibromyalgia was effectively treated with medications, and discontinuing 11 his medication “showed only a 10% increase in his pain symptoms.” AR at 599; 12 see also id. at 600-01 (noting Plaintiff’s pain was treated “only in the form of 13 medications and . . . being off medications for a few months only resulted in a 10% 14 increase in symptoms of pain without the need for further intervention”). 15 “Impairments that can be controlled effectively with medication are not disabling 16 for the purposes of determining eligibility for [disability] benefits.” Warre v. Comm’r, 17 439 F.3d 1001, 1006 (9th Cir. 2006). The ALJ further noted that the treatment plan 18 for Plaintiff’s degenerative joint disease and degenerative disc disease was 19 medication, behavioral therapy and rehabilitation. AR at 599. “[E]vidence of 20 ‘conservative treatment’ is sufficient to discount a claimant’s testimony regarding 21 severity of an impairment.” Parra v. Astrue, 481 F.3d 742, 751 (9th Cir. 2007). The 22 ALJ also noted that Plaintiff “infrequent[ly]” received treatment for his conditions. 23 AR at 599. The ALJ may appropriately “consider lack of treatment in his credibility 24 determination,” Burch v. Barnhart, 400 F.3d 676, 681 (9th Cir. 2005), and may 25 reasonably conclude that “the level or frequency of treatment” is “inconsistent with 26 the level of complaints.” Molina, 674 F.3d at 1114. The ALJ further observed that 27 despite an alleged worsening of Plaintiff’s symptoms and “significantly limit[ed] 28 function,” there was no evidence in the record of escalating treatments or that 1 Plaintiff’s conditions merited “additional intervention” beyond the medications and 2 other conservative measures described. AR 599. The ALJ reasonably concluded 3 that “minimal, conservative treatment” is inconsistent with Plaintiff’s allegation that 4 the pain and fatigue attributable to his impairments rendered him unable to work. 5 Meanel v. Apfel, 172 F.3d 1111, 1114 (9th Cir. 1999), as amended (June 22, 1999). 6 The ALJ also found that Plaintiff’s allegations that his pain limited his daily 7 activities were “not entirely consistent” with the objective medical record, which 8 showed “normal” physical examinations outside of the “tenderness” noted during 9 a 2015 examination. AR at 599. While the ALJ specifically identified reports of 10 physical examinations in 2015 and 2019, he later observed that “the full medical 11 evidence of record” consistently showed “normal examinations despite allegations 12 of pain symptoms.” Id. at 600. It is true that “subjective pain is not always verifiable 13 through a physical examination.” Ferguson, 2024 WL 1103364, at *4. However, 14 “[w]hen objective medical evidence in the record is inconsistent with the claimant’s 15 subjective testimony, the ALJ may indeed weigh it as undercutting such testimony.” 16 Smartt, 53 F.4th at 498 (collecting cases) (emphasis in original). The ALJ found 17 the consistently normal findings on physical examination over a period of years 18 rendered Plaintiff’s allegations that he could not sit upright, walk “down the street,” 19 or use his arms, hands or fingers without pain less than credible. See AR at 600- 20 01, 616-18. This was a “significant and substantial reason[] to find [Plaintiff’s] 21 testimony less than completely credible.” Parra, 481 F.3d at 750 (upholding ALJ’s 22 finding that subjective complaints of pain were contradicted by normal examination 23 findings); Carmickle v. Comm’r, Soc. Sec. Admin., 533 F.3d 1155, 1161 (9th Cir. 24 2008) (“Contradiction with the medical record is a sufficient basis for rejecting the 25 claimant’s subjective testimony.”). 26 Turning next to Plaintiff’s allegations of disabling asthma, Plaintiff testified 27 that he wheezes and “become[s] short of breath” when the weather changes or in 28 humid environments. AR at 614. Approximately once a week, he needs to use an 1 inhaler which “helps” but does not “fully resolve” his symptoms. Id. The ALJ 2 identified that Plaintiff’s asthma was described in the medical records as well- 3 controlled and even “improving” with medication. Id. at 599. The ALJ also 4 observed that Plaintiff’s asthma was conservatively treated and required “no 5 special intervention” beyond medications. Id. Finally, the ALJ noted that the lone 6 pulmonary function test in the record was normal, indicating there were no “deficits” 7 in Plaintiff’s lung functioning. Id. (citing AR at 1710). For the same reasons 8 discussed above, this evidence that Plaintiff’s asthma was conservatively and 9 effectively treated with medication (and nothing else) is a sufficient basis for 10 adverse credibility determination. See Smartt, 53 F.4th at 500. 11 The ALJ also considered the medical opinions and prior administrative 12 findings in the record. See AR at 600. At the initial and reconsideration levels, 13 Drs. Mazuryk and Do, respectively, assessed Plaintiff as capable of light work with 14 some additional environmental restrictions due to Plaintiff’s asthma. Id. at 600. 15 The ALJ found these assessments persuasive, noting Drs. Mazuryk and Do 16 supported their conclusions with citations to “generally normal examinations” and 17 that these findings were “consistent with the full medical evidence of record and 18 are supported by the analysis in the disability determination explanation forms.” 19 Id. However, the ALJ found the consultative internist A. Kanner, M.D.’s opinion 20 that Plaintiff was capable of medium work “less persuasive.” Id. Although Dr. 21 Kanner’s opinion was “supported by the observations made during [a] consultative 22 examination,” the ALJ noted that a review of the “full medical evidence” provided 23 context that could not be “fully examined and realized during this one-time 24 examination.” Id. 25 Based upon his consideration of the objective medical evidence and the 26 opinions and prior administrative findings described above, the ALJ concluded that 27 while Plaintiff “does have underlying impairments that do cause some symptoms 28 of pain,” the foregoing facts demonstrated Plaintiff’s symptoms were “not as 1 significant as alleged.” AR at 600-01. Contrary to Plaintiff’s arguments, given this 2 detailed review of the evidence, the Court is not persuaded that the ALJ improperly 3 extrapolated one or two isolated unremarkable physical examinations to the entire 4 record, or failed to base his assessment on an evaluation of the record as a whole. 5 See Dkt. No. 15 at 6-7. Plaintiff’s related assertion that he has “at least 11 tender 6 points” and fibromyalgia-related symptoms of “significant fatigue,” “widespread 7 pain” and “difficulty sleeping” misses the mark.9 Id. at 8. The ALJ agreed that 8 Plaintiff has fibromyalgia, a severe impairment, as well as other severe 9 impairments that cause him pain, fatigue and related symptoms. AR at 598-99. 10 Rather, the ALJ concluded those symptoms were not disabling. Id. On the record 11 before it, the Court cannot say that determination was arbitrary. Thomas, 278 F.3d 12 at 958. 13 / / / 14
15 16 9 Plaintiff’s complaint that the ALJ did not address his pain, fatigue, and other “symptoms alleged by the fibromyalgia pain,” Dkt. No. 15 at 8, is not well-taken. 17 As Plaintiff acknowledges, his testimony was that due to his pain he had difficulty 18 sitting, standing, using his hands, and sleeping. Id. at 8; see also AR at 616-618. For the reasons discussed herein, the ALJ devoted considerable discussion to 19 Plaintiff’s pain and fatigue and provided several clear and convincing reasons for 20 rejecting Plaintiff’s testimony regarding its the limiting effects. To the extent the ALJ was required to explicitly address each manifestation of Plaintiff’s pain, the 21 Court finds any error in that regard was harmless given the ALJ’s provision of other, 22 adequate reasons for rejecting Plaintiff’s testimony. See Callahan v. Kijakazi, 657 F.Supp.3d 1368, 1387 (E.D. Cal. 2023) (finding harmless error where the ALJ 23 “cited another clear and convincing reason for their credibility determination”); 24 accord Howland v. Saul, 804 F. App’x 467, 470-71 (9th Cir. 2020) (error in discounting claimant’s testimony was harmless where “the ALJ offered several 25 specific, clear and convincing reasons for doing so”). The Court also notes Plaintiff 26 did not give any testimony regarding “his depression,” Dkt. No. 15 at 8, which in any event the ALJ deemed a non-severe impairment that did not cause more than 27 mild limitations in functioning, a finding reflected in the RFC and not challenged in 28 this appeal. See AR at 595-96, 597. 1 The Court finds the ALJ provided “specific, clear and convincing” reasons for 2 his credibility determination, by “enumerat[ing] the objective evidence that 3 undermine[d] [Plaintiff’s] testimony,” Kitchen, 82 F.4th at 739, and “explain[ing] why 4 the medical evidence is inconsistent with the claimant’s subjective testimony.” 5 Ferguson, 2024 WL 1103364, at *4 (emphasis in original). Stated simply, the ALJ 6 “show[ed] his work.” Smartt, 53 F.4th at 499. 7 B. Substantial Evidence Supports the ALJ’s Decision 8 Having found the ALJ supported his credibility determination with clear and 9 convincing reasons, the Court turns to the question of whether that determination, 10 and the resulting finding that Plaintiff was not disabled, is supported by substantial 11 evidence. The Court has independently “assess[ed] the entire record, weighing 12 the evidence both supporting and detracting from the [ALJ’s] conclusion.” See 13 Ahearn, 988 F.3d at 1115. Based on this review, the Court finds substantial 14 evidence supports the ALJ’s conclusions. A summary of that evidence follows.10 15 Office notes from a complete physical examination by Edward Yamada, 16 M.D., dated June 18, 2015 document that Plaintiff complained of “joint pain” that 17 had been ongoing for a year, “especially in the right ankle.” AR at 1371. 18 Examination of his musculoskeletal system revealed tenderness in the right ankle 19 but none in the left, nor in the left or right elbows, wrists, knees, or hands. Id. at 20 1375. His examination was otherwise normal. Id. Dr. Yamada assessed Plaintiff 21 with bronchospasm (improved), chronic sinusitis, joint pain, GERD, depression 22 23 24 10 Plaintiff alleges disability as of June 19, 2015, and last met the insured status 25 requirements of the Act on June 30, 2016 (the “last date insured”). AR at 592. Therefore, and as correctly noted by the ALJ, to be eligible for disability insurance 26 benefits, Plaintiff must have been disabled on or before that date. See id.; accord 27 42 U.S.C. § 416(i)(2) and (3) (defining “period of disability” and eligibility requirements). Plaintiff’s application for supplemental security income is not 28 1 and obstructive sleep apnea, ordered several lab tests, and instructed Plaintiff to 2 follow up in one year. Id. at 1376. On June 24, 2015, Dr. Yamada made a note 3 following what appears to be a discussion with an unnamed rheumatologist that 4 the specialist “doesn’t think pt has rheum sx.” Id. at 1402; see also id. at 1507 (Dr. 5 Yamada’s August 2015 note that a rheumatologist he spoke with in June “didn’t 6 think pt’s condition was outwardly rheumatological”). 7 Dr. Yamada examined Plaintiff again on August 27, 2015, for complaints of 8 joint pain. AR at 1503-09. On examination, Plaintiff exhibited tenderness in his 9 right and left elbows, right and left upper and forearms, and mild tenderness in his 10 right and left upper legs. Id. at 1506-07. Findings for his wrists, knees, ankles, 11 back (cervical, thoracic, and lumbar), and hands were benign. Id. Dr. Yamada 12 diagnosed Plaintiff with “myalgia and joint pain” and ordered lab tests. Id. at 1507, 13 1512-17. On September 3, 2015, Dr. Yamada informed Plaintiff that his “labs are 14 normal” and revealed “no evidence of rheumatological disease.” Id. at 1524. 15 On September 8, 2015, Dr. Yamada reiterated to Plaintiff, “[y]our 16 inflammatory tests are normal and rheumatological markers are negative so I don’t 17 have any explanation for your muscle and joint pain. You don’t quite fit the criteria 18 for fibromyalgia.” AR at 1518. Further lab tests were also normal. Id. at 1534-36. 19 Dr. Yamada diagnosed Plaintiff with chronic pain syndrome and prescribed 20 Cymbalta. Id. Plaintiff reported to Dr. Yamada on September 29, 2015 that the 21 Cymbalta was effective: “I do notice a difference for the better. This is really 22 amazing!! Most of the pain while resting is gone. If I start doing some work, the 23 pain returns, but is not as strong as before.” Id. at 1561. 24 Plaintiff continued to report in 2017 that Cymbalta “relieved 90% [of his] pain” 25 and again in 2019 that Cymbalta “helps a lot” with his pain. Id. at 1690, 1901. 26 Starting in 2019, Plaintiff was also prescribed meloxicam, pregabalin (Lyrica) and 27 gabapentin (Neurontin) for his pain. Id. at 1920, 1947, 1953. In 2017, Plaintiff had 28 a “neg[ative] rheum[atology] eval[uation]” despite complaints of joint pain. Id. at 1 1718. Plaintiff’s physical examinations were largely normal, and Plaintiff denied 2 pain at office visits during this period. AR at 1637, 1834. By 2019, Plaintiff’s 3 physician determined he had fibromyalgia based on positive findings of back pain, 4 joint pain and myalgias. See id. at 1691, 1902. In 2020, Plaintiff ceased all pain 5 medications to participate in a fibromyalgia study, and “[o]nly had increase in pain 6 10% getting off meds.” Id. at 2027. After the study ended, Plaintiff resumed taking 7 Cymbalta. Id.; see also id. at 615 (Plaintiff’s hearing testimony that medication 8 “helped [him] with pain and fatigue” and he anticipated restarting Lyrica at “a proper 9 dose” to increase its efficacy). 10 In 2020, the state agency medical consultant noted upon initial review of the 11 medical record that between the alleged onset date and Plaintiff’s last date insured, 12 Plaintiff received “routine” care for his joint pain and asthma, and his “rheumatology 13 labs were normal.” Id. at 659, 673-74. Following Plaintiff’s fibromyalgia diagnosis, 14 he was treated with medications, his “general physical exam is unremarkable,” and 15 Plaintiff “remains able to drive, do light housework, and is ambulatory” without 16 assistance. Id. at 659, 673-74. On reconsideration, another state agency medical 17 consultant also noted that despite “ongoing issues due to fibromyalgia,” Plaintiff’s 18 activities of daily living demonstrated he remained “functional,” and able to work 19 subject to certain limitations. Id. at 693. 20 In March 2021, Plaintiff was seen by his primary care physician, who noted 21 Plaintiff’s back pain and fibromyalgia were “stable.” AR at 2152-54. Physical 22 examination was positive for back pain. Id. at 2153. An x-ray of Plaintiff’s 23 lumbosacral spine taken the same day showed degenerative disc disease at L5- 24 S1. Id. at 2158. On a March 30, 2021 follow up with a physical medicine specialist, 25 reported that he had “pain across the lower back . . . daily and all the time.” Id. at 26 2261. Plaintiff further stated sitting, standing and walking were all painful for him, 27 but denied numbness or tingling associated with his back pain. Id. Examination 28 revealed tenderness to palpation of more than 11 of 18 fibromyalgia trigger points. 1 Id. at 2262. The specialist recommended guided injections. Id. at 2263. On April 2 19, 2021, chronic pain specialist G. Goldwaser, Ph.D. recommended “education” 3 and cognitive behavioral therapy to address Plaintiff’s complaints of pain. Id. at 4 2409-11. The consultative examiner’s report of her September 2021 examination 5 documents findings of tenderness at 10 out of 18 fibromyalgia trigger points, and 6 a lower back examination that was “within normal limits.” Id. at 3045. 7 The objective medical record also demonstrates that Plaintiff’s asthma was 8 well-controlled with an inhaler and other medications, by both subjective report and 9 objective findings. See, e.g., AR at 1362 (Plaintiff’s self-report of asthma 10 “symptoms” which were alleviated by use of an albuterol inhaler); 1691 11 (“intermittent asthma” under “good control”), 1901 (“seasonal” asthma relieved by 12 medication), 2152 (“asthma stable no wheezing or s[hortness] o[f] b[reath]”). 13 Plaintiff variously reported that exposure to “strong chemicals,” high humidity and 14 air conditioning worsened his symptoms. Id. at 1437, 1499, 1699. However, 15 pulmonary function tests and sinus imaging were normal. Id. at 1710, 1437, 1455. 16 Plaintiff’s pulmonologist informed Plaintiff on January 31, 2017 that the results of 17 his “breathing tests” were “normal,” which did not “exclude asthma . . . [but] usually 18 means there is not severe or uncontrolled asthma.” Id. at 1714. The September 19 2021 consultative examination report documents an increased respiratory rate with 20 exertion, without evidence of shortness of breath or wheezing. Id. at 3042, 3045. 21 The Court finds the foregoing is relevant and substantial evidence adequate 22 to support the ALJ’s adverse credibility assessment, and the subsequent 23 determination based on Plaintiff’s RFC that he was not disabled. Accordingly, the 24 ALJ’s decision will not be disturbed. See Ahearn, 988 F.3d at 1115 (“If substantial 25 evidence in the record supports the ALJ’s decision we must defer to the ALJ.”); 26 see also 42 U.S.C.A. § 405(g) (providing that “[t]he findings of the Commissioner 27 of Social Security as to any fact, if supported by substantial evidence, shall be 28 conclusive”). 1 V. 2 CONCLUSION 3 For the foregoing reasons, the Court concludes that the ALJ’s decision was 4 legally erroneous and was supported by substantial evidence. Plaintiffs 5 ||request for reversal and remand is therefore DENIED. The final decision of the 6 ||Commissioner of Social Security is AFFIRMED. The Clerk of the Court shall enter 7 ||judgment accordingly and terminate the case. 8 IS SO ORDERED. 9 || Dated: March 26, 2024 ait Ctl edb 11 ‘Hon. DavidD.Leshner □□□ 12 United States Magistrate Judge 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28